Contrarius Group Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.2M Buy
2025
Q1
$11.3M Sell
2024
Q4
$14.5M Buy